{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:10:50Z","timestamp":1792609850920,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Osteoporosis (OP) tends to occur in postmenopausal women, making them prone to fractures. <jats:italic>N<\/jats:italic>6-methyladenosine (m6A) methylation plays a crucial role in OP. Herein, we aimed to explore the effects of METTL14 on osteogenesis and the underlying mechanism. Osteogenic differentiation was assessed through osteoblast markers expression, cell proliferation, ALP activity, and mineralization, which were detected by qRT-PCR, CCK-8, EdU assay, ALP staining assay, and ARS staining assay, respectively. Osteoporosis was evaluated in OVX mice using qRT-PCR, microcomputed tomography, and H&amp;E staining assay. The levels of METTL14 and SMAD1 were measured using qRT-PCR and western blot, and their interaction was assessed using RIP and luciferase reporter assay. M6A methylation was analyzed using the Me-RIP assay. The results indicated that m6A, METTL14, and SMAD1 levels were downregulated in patients with OP and OVX mice, and upregulated in osteogenic BMSCs. Knockdown of METTL14 suppressed osteogenesis of BMSCs and reduced bone mass of OVX mice. Moreover, silencing of METTL14 positively related to SMAD1 and inhibited m6A modification of SMAD1 by suppressing its stability. IGF2BP1 was identified as the methylation reader, and which knockdown reversed the upregulation induced by SMAD1. Overexpression of SMAD1 reversed the suppression of osteogenic differentiation induced by METTL14 knockdown. In conclusion, interference with METTL14 inhibited osteogenic differentiation of BSMCs by m6A modification of SMAD1 in an IGFBP1 manner, suggesting that METTL14 might be a novel approach for improving osteoporosis.<\/jats:p>","DOI":"10.1038\/s41419-022-05362-y","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T17:09:06Z","timestamp":1667322546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1"],"prefix":"10.1038","volume":"13","author":[{"given":"Chaoqing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-1371","authenticated-orcid":false,"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"5362_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-981-13-1117-8_13","volume":"1086","author":"L Li","year":"2018","unstructured":"Li L, Wang Z. Ovarian aging and osteoporosis. Adv Exp Med Biol. 2018;1086:199\u2013215.","journal-title":"Adv Exp Med Biol"},{"key":"5362_CR2","first-page":"92","volume":"43","author":"KN Tu","year":"2018","unstructured":"Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, et al. Osteoporosis: a review of treatment options. P T. 2018;43:92\u2013104.","journal-title":"P T."},{"key":"5362_CR3","doi-asserted-by":"publisher","first-page":"ITC17","DOI":"10.7326\/AITC201708010","volume":"167","author":"KE Ensrud","year":"2017","unstructured":"Ensrud KE, Crandall CJ. Osteoporosis. Ann Intern Med. 2017;167:ITC17\u2013ITC32.","journal-title":"Ann Intern Med"},{"key":"5362_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.beem.2018.05.003","volume":"32","author":"P Szulc","year":"2018","unstructured":"Szulc P. Bone turnover: biology and assessment tools. Best Pr Res Clin Endocrinol Metab. 2018;32:725\u201338.","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"5362_CR5","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","volume":"5","author":"R Eastell","year":"2017","unstructured":"Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5:908\u201323.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5362_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.beem.2018.09.005","volume":"32","author":"R Rizzoli","year":"2018","unstructured":"Rizzoli R. Postmenopausal osteoporosis: assessment and management. Best Pr Res Clin Endocrinol Metab. 2018;32:739\u201357.","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"5362_CR7","doi-asserted-by":"crossref","unstructured":"Chen T, Yang T, Zhang W, Shao J. The therapeutic potential of mesenchymal stem cells in treating osteoporosis. Biol Res. 2021;54:42.","DOI":"10.1186\/s40659-021-00366-y"},{"key":"5362_CR8","first-page":"2267","volume":"43","author":"W Zhu","year":"2019","unstructured":"Zhu W, Wang JZ, Xu Z, Cao M, Hu Q, Pan C, et al. Detection of N6-methyladenosine modification residues (Review). Int J Mol Med. 2019;43:2267\u201378.","journal-title":"Int J Mol Med"},{"key":"5362_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176.","journal-title":"Mol Cancer"},{"key":"5362_CR10","doi-asserted-by":"publisher","first-page":"113829.","DOI":"10.1016\/j.expneurol.2021.113829","volume":"345","author":"Q Wang","year":"2021","unstructured":"Wang Q, Liang Y, Luo X, Liu Y, Zhang X, Gao L. N6-methyladenosine RNA modification: a promising regulator in central nervous system injury. Exp Neurol. 2021;345:113829.","journal-title":"Exp Neurol"},{"key":"5362_CR11","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.7150\/ijbs.45231","volume":"16","author":"ZM Zhu","year":"2020","unstructured":"Zhu ZM, Huo FC, Pei DS. Function and evolution of RNA N6-methyladenosine modification. Int J Biol Sci. 2020;16:1929\u201340.","journal-title":"Int J Biol Sci"},{"key":"5362_CR12","doi-asserted-by":"publisher","first-page":"e13298.","DOI":"10.1111\/acel.13298","volume":"20","author":"Z Sun","year":"2021","unstructured":"Sun Z, Wang H, Wang Y, Yuan G, Yu X, Jiang H, et al. MiR-103-3p targets the m(6) A methyltransferase METTL14 to inhibit osteoblastic bone formation. Aging Cell. 2021;20:e13298.","journal-title":"Aging Cell"},{"key":"5362_CR13","doi-asserted-by":"publisher","first-page":"926.","DOI":"10.3892\/etm.2021.10358","volume":"22","author":"Y Hu","year":"2021","unstructured":"Hu Y, Zhao X.Role of m6A in osteoporosis, arthritis and osteosarcoma (Review). Exp Ther Med. 2021;22:926.","journal-title":"Exp Ther Med"},{"key":"5362_CR14","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3389\/fendo.2019.00911","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, Hua W, Huang X, Chen Y, Zhang J, Li G. Regulatory role of RNA N(6)-methyladenosine modification in bone biology and osteoporosis. Front Endocrinol. 2020;10:911","journal-title":"Front Endocrinol"},{"key":"5362_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00774-021-01297-0","volume":"40","author":"Z Zou","year":"2022","unstructured":"Zou Z, He T, Liu Y, Zheng L, Zhong Y, Mo Y, et al. Emerging role of m6A modification in osteogenesis of stem cells. J Bone Min Metab. 2022;40:177\u201388.","journal-title":"J Bone Min Metab"},{"key":"5362_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i2.20","volume":"19","author":"CJ Rosen","year":"2009","unstructured":"Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM. Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr. 2009;19:109\u201324.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"5362_CR17","doi-asserted-by":"publisher","first-page":"783322.","DOI":"10.3389\/fcell.2021.783322","volume":"9","author":"M Huang","year":"2021","unstructured":"Huang M, Xu S, Liu L, Zhang M, Guo J, Yuan Y, et al. m6A methylation regulates osteoblastic differentiation and bone remodeling. Front Cell Dev Biol. 2021;9:783322.","journal-title":"Front Cell Dev Biol"},{"key":"5362_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06898-4","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Xie L, Wang M, Xiong Q, Guo Y, Liang Y, et al. Mettl3-mediated m(6)A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun. 2018;9:4772.","journal-title":"Nat Commun"},{"key":"5362_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.omtn.2019.12.001","volume":"19","author":"G Yan","year":"2020","unstructured":"Yan G, Yuan Y, He M, Gong R, Lei H, Zhou H, et al. m6A methylation of precursor-miR-320\/RUNX2 controls osteogenic potential of bone marrow-derived mesenchymal stem cells. Mol Ther Nucleic Acids. 2020;19:421\u201336.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5362_CR20","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3390\/cells8121579","volume":"8","author":"J Nickel","year":"2019","unstructured":"Nickel J, Mueller TD. Specification of BMP signaling. Cells. 2019;8:1579.","journal-title":"Cells."},{"key":"5362_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00296-7","volume":"9","author":"J Wu","year":"2021","unstructured":"Wu J, Zhang M, Faruq O, Zacksenhaus E, Chen W, Liu A, et al. SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma. Biomark Res. 2021;9:48.","journal-title":"Biomark Res"},{"key":"5362_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.joca.2011.03.004","volume":"19","author":"M Wang","year":"2011","unstructured":"Wang M, Jin H, Tang D, Huang S, Zuscik MJ, Chen D. Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthr Cartil. 2011;19:751\u201362.","journal-title":"Osteoarthr Cartil"},{"key":"5362_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2005.06.017","volume":"357","author":"X Cao","year":"2005","unstructured":"Cao X, Chen D. The BMP signaling and in vivo bone formation. Gene. 2005;357:1\u20138.","journal-title":"Gene."},{"key":"5362_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2174\/187153008785700127","volume":"8","author":"B Li","year":"2008","unstructured":"Li B. Bone morphogenetic protein-Smad pathway as drug targets for osteoporosis and cancer therapy. Endocr Metab Immune Disord Drug Targets. 2008;8:208\u201319.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"5362_CR25","first-page":"505","volume":"35","author":"HB Zheng","year":"2021","unstructured":"Zheng HB, Wu M, Zhang G, Chen KL. MicroRNA-182 inhibits osteogenic differentiation of bone marrow mesenchymal stem cells by targeting Smad1. J Biol Regul Homeost Agents. 2021;35:505\u201316.","journal-title":"J Biol Regul Homeost Agents"},{"key":"5362_CR26","doi-asserted-by":"crossref","unstructured":"Huang Q, He W, Weng Y, Wang Y, Liu Y, Xiang Y, et al. Berberine inhibits osteogenic differentiation of aortic valve interstitial cells by interfering Smad1\/5\/8 and NF-kappaB pathways. Vascul Pharmacol. 2022;144:106986.","DOI":"10.1016\/j.vph.2022.106986"},{"key":"5362_CR27","doi-asserted-by":"publisher","first-page":"232.","DOI":"10.1186\/s13287-018-0976-0","volume":"9","author":"X Li","year":"2018","unstructured":"Li X, Zheng Y, Zheng Y, Huang Y, Zhang Y, Jia L, et al. Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7\/GDF5\/SMAD and p38 MAPK signaling pathway. Stem Cell Res Ther. 2018;9:232.","journal-title":"Stem Cell Res Ther"},{"key":"5362_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1359\/jbmr.071011","volume":"23","author":"E Luzi","year":"2008","unstructured":"Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Min Res. 2008;23:287\u201395.","journal-title":"J Bone Min Res"},{"key":"5362_CR29","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/stem.3428","volume":"39","author":"X Liu","year":"2021","unstructured":"Liu X, Liu X, Du Y, Hu M, Tian Y, Li Z, et al. DUSP5 promotes osteogenic differentiation through SCP1\/2-dependent phosphorylation of SMAD1. Stem Cells. 2021;39:1395\u2013409.","journal-title":"Stem Cells"},{"key":"5362_CR30","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/jcb.25092","volume":"116","author":"A Tasca","year":"2015","unstructured":"Tasca A, Stemig M, Broege A, Huang B, Davydova J, Zwijsen A, et al. Smad1\/5 and Smad4 expression are important for osteoclast differentiation. J Cell Biochem. 2015;116:1350\u201360.","journal-title":"J Cell Biochem"},{"key":"5362_CR31","doi-asserted-by":"publisher","first-page":"1288.","DOI":"10.1038\/s41556-020-00580-y","volume":"22","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2020;22:1288.","journal-title":"Nat Cell Biol"},{"key":"5362_CR32","doi-asserted-by":"publisher","first-page":"74.","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"5362_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/term.3279","volume":"16","author":"X Li","year":"2022","unstructured":"Li X. LncRNA metastasis-associated lung adenocarcinoma transcript-1 promotes osteogenic differentiation of bone marrow stem cells and inhibits osteoclastic differentiation of M\u00f8 in osteoporosis via the miR-124-3p\/IGF2BP1\/Wnt\/\u03b2-catenin axis. J Tissue Eng Regen Med. 2022;16:311\u201329.","journal-title":"J Tissue Eng Regen Med"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05362-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05362-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05362-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T17:09:47Z","timestamp":1667322587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05362-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["5362"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05362-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"23 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study. All the participants were consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study was supported by the Ethics Committee of the Second Affiliated Hospital of Navy Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"919"}}